subscribeSubscribe
U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents

U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents
REUTERS
28 Mar 2023
Share Share
Amgen-Sanofi patent case divides makers of antibody drugs

Amgen-Sanofi patent case divides makers of antibody drugs
REUTERS
27 Mar 2023
Share Share
Amgen hits back at Sanofi, Regeneron in long-running patent feud

Amgen hits back at Sanofi, Regeneron in long-running patent feud
FIERCE PHARMA
09 Mar 2023
Share Share
Amgen To Present New Repatha® (Evolocumab) And Olpasiran Data At Acc

Amgen To Present New Repatha® (Evolocumab) And Olpasiran Data At Acc
PR NEWSWIRE
01 Mar 2023
Share Share
Philip Tagari switches Amgen`s discovery lab for insitro`s machine tools

Philip Tagari switches Amgen`s discovery lab for insitro`s machine tools
Alex Hoffman ENDPTS
02 Dec 2022
Share Share
Amgen asks Supreme Court to take up PCSK9 patent case against Sanofi & Regeneron

Amgen asks Supreme Court to take up PCSK9 patent case against Sanofi & Regeneron
Fraiser Kansteiner FIERCEPHARMA
08 Nov 2022
Share Share
Amgen Data at ESC Show LDL-C Lowering With Repatha Was Tolerated For 8 Years

Amgen Data at ESC Show LDL-C Lowering With Repatha Was Tolerated For 8 Years
PRNEWSWIRE
29 Aug 2022
Share Share
Amgen touts longterm Repatha data, hunts billions for PCSK9 franchise

Amgen touts longterm Repatha data, hunts billions for PCSK9 franchise
John Carroll ENDPTS
27 Apr 2022
Share Share
SCOTUS summons help to weigh Amgen PCSK9 patent appeal

SCOTUS summons help to weigh Amgen PCSK9 patent appeal
Fraiser Kansteiner FIERCEPHARMA
21 Apr 2022
Share Share
Supreme Court calls on top government lawyer to weigh PCSK9 patent appeal

Supreme Court calls on top government lawyer to weigh PCSK9 patent appeal
T. Patchen ENDPTS
21 Apr 2022
Share Share